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ABSTRACT
The dopamine D3 receptor (D3R) is an important pharmacotherapeutic target for its 
potential role in psychiatric disorders and drug dependence. To further explore its 
function in rats, a regulatable lentivirus, Lenti-D3, holding the rat D3R cDNA has 
been constructed as well as three lentiviruses, Lenti-D3-Sils, expressing small hairpin 
RNAs, aimed at silencing D3R expression and specifically targeted against different 
regions of the D3R mRNA. In vitro Lenti-D3 expressed D3R and could efficiently be 
blocked with Lenti-D3-Sils. These viruses were stereotaxically injected into the shell 
part of the nucleus accumbens (NAcc) and effects of passive cocaine delivery on 
locomotor activity were assessed. Manipulations of D3R levels induced changes in 
the locomotor stimulant effects of cocaine as compared to control treatment. 
Suppression of DA D3R in the NAcc by means of local knockdown (with Lenti-D3-
Sils) increased locomotor stimulant effects, whereas its overexpression with Lenti-D3 
drastically reduced them. The latter effects could be reversed when animals were fed 
doxycycline, that prevented lentiviral-mediated DA D3R overexpression in the NAcc. 
Gene expression assessed by quantitative RT-PCR confirmed very efficient gene 
knock-down in vivo in animals treated with Lenti-D3-Sils (>93% silencing of D3R
gene). Thus D3R expression significantly contributes to behavioral changes 
associated with chronic cocaine delivery.
Key Words: Dopamine D3-Receptor, Cocaine, Addiction, Plasticity, Drugs of Abuse, 
siRNA, Lentivirus, in vivo Gene Transfer 
List of abbreviations: NAcc: Nucleus Accumbens; DA D2R: dopamine D2 receptor 
DA D3R: dopamine D3 receptor; uPA: Urokinase-type plasminogen activator; 
HEK293T: Human Embryonic Kidney 293T cells; GFP: green fluorescent protein.
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INTRODUCTION
Dopamine is a major neurotransmitter in the brain, where it plays an important role 
in controlling motor function and behavioral homeostasis. It exerts its effects through 
receptors, which, based on their structural and functional properties, are divided into 
‘D1-like’ (DA D1R and DA D5R) and ‘D2-like’ (DA D2R, DA D3R and DA D4R)
subgroups (Strange 1993). Among them, the DA D3R has a unique expression profile 
in the brain: it displays preferential localization in the mesocorticolimbic system, in 
regions that are thought to influence motivation and motor functions. (Levant 1998; 
Shafer & Levant 1998, Suzuki et al. 1998, Xu et al. 1997), and highest distributions in 
limbic parts of the striatum complex, including the islands of Calleja, olfactory 
tubercles, anterior and shell parts of the nucleus accumbens (NAcc) and the bed 
nucleus of stria terminalis (Bouthenet et al. 1991; Diaz et al. 1995; Landwehrmeyer et
al. 1993a; Sokoloff et al. 1990). It plays a key role in several neuropsychiatric disorders 
including schizophrenia and addiction (Schmauss, 1996, Schmauss et al., 1993, Staley 
and Mash, 1996,) and rewarding properties of cocaine could be mediated specifically 
(at least) through interaction at the DA D3R (Ritz et al, 1987). D3R-selective agonists 
inhibit cocaine-seeking behaviour that depends upon the presentation of drug-
associated cues, without having any intrinsic, primary rewarding effects (Pilla et al.,
1999). Being less widely distributed than DA D1R and DA D2R, its restricted 
distribution makes it a promising target for the development of clinical compounds, 
reducing the risk of undesirable side effects. Distribution of DA D3R mRNA partially 
overlaps with, but is different from that of DA D2R. Morover, the DA D1R and DA 
D3R are co-expressed in neurons, particularly in the NAcc and in the caudate 
putamen (Surmeier et al., 1996, Le Moine and Bloch, 1996) and can exert both 
opposite and analogous effects in the brain: for example, DA D1R and DA D3R
mutant mice exhibit attenuated or enhanced locomotor activity after acute cocaine 
treatment, respectively, compared with wild type mice, an effect not associated with 
anxiety state; moreover, D3R mutant mice exhibit enhanced behavioral sensitivity to 
combined injections of D1R and D2R agonists (Xu et al., 1997), but they exhibit 
cooperative effects on substance P expression in the NAcc and opposite regulatory 
effects on c-Fos expression in the islands of Calleja (Schwartz et al., 1998; Ridray et al.,
1998). Thus D1R and D3R may affect neurons in either synergy or opposition 
according to the cell or signal generated and it has been postulated that imbalances 
between the levels of D1 and D3 receptors in the same neurons could be responsible 
for schizophrenic disorders (Schwartz et al., 1998). 
The aim of the present study was to investigate the role of DA D3R in cocaine-
induced hyperlocomotion. For this purpose, a regulatable lentivirus holding the rat 
DA D3R cDNA under the control of a tetracycline-inducible promoter was 
constructed together with several lentiviruses expressing DA D3R-specific siRNAs, 
targeted against different regions of the DA D3R mRNA. These viruses were tested in
vitro, by means of quantitative real-time PCR and immunocytochemistry using 
HEK293T cells, and in vivo in rats, by stereotaxic injection of the lentiviruses into the 
shell part of the NAcc. Our studies show that DA D3R expression in the NAcc 
significantly contributes to behavioral changes associated with chronic cocaine 
delivery. Overexpression of DA D3R in this brain area induces a 50% decrease in 
cocaine-induced locomotor activity that can be reversed to normal in the same 
3
ht
tp
://
do
c.
re
ro
.c
h
animal fed doxycycline. Furthermore, local knockdown of DA D3R in the NAcc, 
efficiently achieved in vivo with lentiviruses expressing DA D3R-specific siRNAs, 
results in significant cocaine-induced behavioral changes. 
4
ht
tp
://
do
c.
re
ro
.c
h
Experimental Procedure
Animal Handling and Drug delivery Protocols :
Animals used in this experiment were male Wistar rats weighing 225-250 g (BRL, 
Füllinsdorf, Switzerland). All animal experiments were carried out in accordance 
with the guidelines and regulations for Animal Experimentation, BAG, Bern, 
Switzerland. The animals were housed in trios in clear plastic cages with wire grid 
lids. Access to food and water was unrestricted. The animals were kept in the animal 
facility maintained on a 12-h light: 12-h dark cycle (lights off at 07:00 am). Three 
different protocols for Drug administration were used: (i) Acute Paradigm: animals
(n=6) were i.p. injected once with 15 mg/kg cocaine-HCl. (ii) Chronic Paradigm:
animals (n=6) were i.p. injected daily with 15 mg/kg cocaine-HCl for a period of 15 
days. (iii) Binge Paradigm: animals (n=6) were i.p. injected with 30 mg/kg cocaine-
HCl every 2 hours for 4 injections.  
In all three protocols control animals received 0.9% saline i.p. injection instead of 
drug under the same schedule. 24 hours after the last injection, animals were 
sacrificed by decapitation. The NAcc (core and shell) were dissected out and used for 
isolation of total RNA, using TRIzol Reagent (Invitrogen, Switzerland) followed by 
RNA amplification, according to previous publications (Bahi et al., 2004b, Bahi and 
Dreyer 2004, Kacharmina et al., 1999). 
Microarray studies:
Microarray design and analysis was done according to published methods (Shalon et
al., 1996). Briefly, specific oligonucleotides were synthesized with 5’-amino 
modification and arrayed onto QMT Aldehyde Slides (Quantifoil, Germany) and 
stored at room temperature for further hybridizations.
Probe design was according to previous publications (Bahi and Dreyer, 2004; Bahi et 
al., 2004b) and recommendations by QIAGEN™. 70mer probes were designed for 10 
negative and 10 positive control genes, DA D3R and DA D2R. Oligonucleotides 
sequences of positive and negative controls are patented (QIAGEN™, Basel, 
Switzerland). The following oligonucleotides were used: DA D3R: 5’-CAA AGC CTT 
CCT CAA GAT CCT GTC CTG CTG AAG GAG GAG AAG AGA CCG CAC TCC 
TTT ACC ACT TCG AGA T-3’; DA D2R: 5’-CCA GGA TTG CCA AGT TCT TTG 
AGA TCC AGA CCA TGC CCA ATG GCA AAA CCC GGA CCT CCC TTA AGA 
CGA T-3’. 
For probe preparation, each amplified RNA sample (one from control sample and 
one from treated sample) was reverse-transcribed in the presence of Cy3-dCTP 
(control samples) or Cy5-dCTP (treated samples) and purified, according to previous 
publications (Bahi and Dreyer 2004; Bahi et al., 2004a, b). After hybridization, slides 
were scanned; ratios of experimental (Cy5) versus control (Cy3) signals were 
normalized after background subtraction. 
Data sets were further statistically analyzed and p-values evaluated using a stringent 
cut-off for significance. Induction or repression of a gene was defined as a minimum 
1.5-fold change in its transcript level. Genes were considered to be down-regulated if 
the ratio of experimental vs. control was between 0.12 and 0.5 (or between -0.12 and –
0.5) with P<0.01 or up-regulated if the ratio of experimental vs. control was 2 or more 
with P<0.01 (Bahi et al., 2004b, Bahi and Dreyer 2004). 
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Construction of Lenti-D3:
The DA D3R cDNA (GenBank accession no. X53944) was amplified by reverse 
transcription. Briefly, 2 Pg of total RNA (prepared from rat NAcc of cocaine-treated 
animals) were added to 1 Pg Oligo-(dT)12-18, 2 Pl of dNTP Mix at 10 mM each and 
made up to 12 Pl with RNase free-water. These components were mixed and heated 
at 65°C for 5 min, then kept on ice. To the mixture 4 Pl of 5X first strand buffer was 
added, followed by 2 Pl 0.1M DTT, 10 U RNAsin (Invitrogen, Switzerland), 1 Pl 200 
U/Pl Superscript II RNaseH- Reverse Transcriptase, (Invitrogen, Switzerland). The 
mixture was incubated at 42°C for 3 hours. To remove RNA-DNA hybrids, 2 U 
RNase H (Invitrogen, Switzerland) were added and incubated at 37°C for 30 min. 
The cDNA was then PCR amplified and flagged with the two following primers: 5’- 
GGA AGA TCT ATG GAC TAC AAG GAC GAC GAT GAC AAG GCA CCT CTG 
AGC CAG-3’ and 5’-CCG CTC GAG CGG TCA GCA GGA CAG GAT CTT-3’ 
(restriction sites are underlined). The forward primer contains a Bgl-II restriction site 
followed by the flag epitope sequence (in bold) and the 5’ Rat DA D3R cDNA specific 
sequence, the reverse primer contains the 3’ Rat D3R cDNA specific sequence, a stop 
codon and an Xho-I restriction site. The PCR product was digested with Bgl-II and 
Xho-I and cloned into BamH-I/Xho-I sites in pTK431. 
The GFP expression vector pTK433 (Bahi et al. 2004a, b) was used as a control vector. 
Construction of Lenti-D3-siRNAs:
To silence DA D3R expression in vitro and in vivo, 3 targets were designed according 
to the DA D3R mRNA sequence. The following targets within the DA D3R sequence 
were selected, based on Hannon’s design criterion 
(http://katahdin.cshl.org:9331/RNAi/html/rnai.html): 1st target: bp 165–184, 2nd
target: bp 201–220, 3rd target: bp 277–296. To each oligo, an Xho-I restriction site was 
added at 3’ and a U6-3’-specific 10mer at 5’. Using the pSilencer 1.0-U6 (Ambion, UK) 
as a template and a U6 promoter-specific forward primer containing BamH-I
restriction site (GCG GAT CCC GCT CTA GAA CTA GTG C), each siRNA target was 
added to the mouse U6 promoter by PCR. The PCR conditions were highly drastic to 
avoid mutations within the targets. The following PCR program was performed: 120 
s at 94 °C (initial denaturation) followed by 94° C – 45 s, 64 °C – 45 s and 72 °C – 45 s 
repeated 35 cycles. The PCR reaction contains 4% dimethyl sulfoxide (Sigma, 
Switzerland). The PCR product was digested with BamH-I and Xho-I, cloned into 
similar sites into pTK431, and sequenced to verify the integrity of each construct. 
Lentivirus Production:
The vector plasmids (either pTK431-D3, pTK433-GFP or pTK431-U6-D3-siRNAs), 
together with the packaging construct plasmid p¨NRF and the envelope plasmid 
pMDG-VSV-G were co-transfected into HEK293T cells to produce the viral particles 
(Bahi et al. 2004a, b). The viral titers were determined by p24 antigen measurements 
(KPL, USA). For the in vivo experiments, the different viral stocks were matched for 
viral particle content and used at 0.2 mg/ml of p24. 
In vitro DA D3R Transcripts Quantification Assays:
The efficiency of the Lenti-D3 was tested in vitro by infection of HEK293T cells. 1 x 
105 HEK293T cells were plated per well in 6-well plates. The next day, lentiviruses 
stocks were mixed with 10 Pg/ml Polybrene (Sigma, Switzerland) with/without 30 
ng/ml doxycycline (Sigma, Switzerland), incubated for 30 min at room temperature, 
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added to the cells and incubated at 37°C. After 48 h the medium was replaced with 
normal growth medium (with or without 30 ng/ml doxycycline) and cells were left 
for further 48h. Cells were then collected and used for total RNA isolation (for real-
time PCR). Infections with the different lentiviruses were done as follows: a)
doxycycline regulation: cells were co-infected using 0, 2, 4 or 8 Pl of Lenti-D3 stock 
together with either 4 Pl of Lenti-CD81-His6 (Bahi et al., 2004a) or 4 Pl of Lenti-uPA-
His6 (Bahi et al., 2004b) and one part of the cells was incubated in the presence of 30 
ng/ml doxycycline and the other part without doxycycline; b) in vitro silencing of 
DA D3R: cells were infected with 4 Pl of Lenti-D3 stock, either alone or together with: 
4 Pl of Lenti-GFP, 4 Pl of Lenti-CD81-His6 (Bahi et al., 2004a), 4 Pl of Lenti-uPA-His6 
(Bahi et al., 2004b), as well as 2 Pl of Lenti-D3-siRNA1, 2 Pl of Lenti-D3-siRNA2, 2 Pl
of Lenti-D3-siRNA3, or with 2 or 4 Pl of all three targets together (mix of Lenti-D3-
siRNA1, Lenti-D3-siRNA2 and Lenti-D3-siRNA3). 
Stereotaxic surgery
Stereotaxic surgery and injection of the lentiviral vectors were performed according 
to previous publications (Bahi et al., 2004a, b). Animals (n=9) were bilaterally injected 
into the shell part of the NAcc with concentrated lentiviral stock (0.2 mg/ml of p24, 
corresponding to 8x109 IU/ml), either 2 Pl of Lenti-D3 stock alone in a first group of 
animals, or 2 Pl Lenti-D3 together with 2 Pl of Lenti-D3-siRNAs mix in a second 
group of animals, or 2 Pl Lenti-GFP in a third group of animals (control); finally, a 
last group of animals was infected with 2 Pl Lenti-GFP together with 2 Pl of Lenti-D3-
siRNAs mix, with the aim to suppressing expression of endogenous DA D3R receptor 
upon cocaine delivery. All injections were performed bilaterally at following 
coordinates, as calculated from bregma and the dura mera: anterior +1.4; lateral +/-
1.2; ventral -7.8 (Paxinos and Watson, 1998). After surgery animals were left for 
recovery during 7 days, then cocaine-treated and behavior assessed following a 
chronic protocol. Animals were fed 5% sucrose in drinking water for 5 days (session 
“A”), then 0.02% doxycycline and 5% sucrose in water for 5 further days (session 
“B”), then again 5% sucrose for 5 more days (session “C”).
In vivo DA D3R Transcripts Quantification Assays:
At the end of each behavioral session “A”, “B” and “C”, three animals were 
sacrificed by decapitation to assess the efficiency of the Lenti-D3 expression in vivo;
brains (n=3) were dissected out, NAcc region was isolated and total RNA was 
extracted using TRIzol Reagent (Invitrogen, Switzerland). RNA was used for 
transcripts quantification. 
Quantitative real-time PCR and quantification of DA D3R Transcripts:
For quantitative real-time PCR, primer sets for rat DA D2R and DA D3R, GAPDH, E-
actin, rat uPA and rat CD81 were designed to amplify 100- to 200-bp products, using 
PRIMER3 software: (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi).
Following specific primer pairs were used; DA D2R: 5’-CAT TGT CTGGGT CCT GTT 
CCT-3’ and 5’- GAC CAG CAG AGT GACGAT GA-3’. DA D3R: 5’- GGG GTG ACT 
GTC CTG GTC TA-3’ and 5’- TGG CCC TTA TTG AAA ACT GC-3’. GAPDH: 5’-
ATG ACT CTA CCC ACG GCA AG-3’ and 5’-CAT ACT CAG CAC CAG CAT CAC-
3’. E-actin: 5’- AGC CAT GTA CGT AGC CAT CC-3’ and 5’-CTC TCA GCT GTG 
GTG GTG AA-3’. uPA: 5’- CAG ATC CGA TGC TCT TAG CC-3’ and 5’- TAG AGC 
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CTT CTG GCC ACA CT-3’. CD81: 5’- TGA TCCTGT TTG CCT GTG AG-3’ and 5’- 
CAG TTG AGC GTC TCA TGG AA-3’. GAPDH was used as endogenous control for 
normalization. Total RNA was extracted from the HEK293T cells (for in vitro
quantification) and from the Nacc of brains of cocaine treated animals (for in vivo
quantification) using TRIzol Reagent (Invitrogen, Switzerland) including an RNase-
free DNase step. RNA was quantified by spectrophotometry, and its integrity 
verified by agarose gel electrophoresis as visualized with ethidium bromide staining. 
First strand cDNA was generated from 2 Pg of total RNA and Oligo(dT12-18) primer 
with the M-MLV reverse transcription kit (Invitrogen, Switzerland) in a total volume 
of 20 Pl. The reaction product was used for quantitative real-time PCR using the real-
time PCR iCycler (BioRad, Switzerland). 5 Pl cDNA preparation, 0.5 PM of forward 
and reverse primers and 10 Pl of IQ SYBR Green Supermix (Biorad, Switzerland) in a 
total volume of 20 Pl were applied and PCR was performed as follows: 3 min at 95°C 
(initial denaturation); 20°C/sec temperature transition rate up to 95°C for 45 sec, 45 
sec 62°C, repeated for 40 times (amplification). The PCR reaction was evaluated by 
melting curve analysis and by checking the PCR products on 2% agarose gel. 
The PCR cycle number at which each assay target reached the threshold detection 
line was determined (“threshold cycles”, Ct value). The Ct of each gene was 
normalized against that of GAPDH or E-actin. To determine the linearity and 
detection limit of the assay, cDNA samples were amplified for successive 10-fold 
dilutions in a series of real-time PCRs, using duplicate assay on each dilution, so that 
the correlation coefficient could be calculated from the standard curve of Ct values. 
Comparisons were made between cocaine and saline groups and significance was 
calculated using two-tailed Student’s t-test and the level of statistical significance was 
set at P<0.05. Data were expressed as mean ± SEM. The ¨Ct for each candidate was 
calculated as ¨Ct = [Ct (candidate) – Ct (GAPDH or E-actin)]. The relative abundance 
of each target in each protocol can be calculated as the ratio between treated and 
untreated samples (Mühlbauer et al., 2004, Bahi and Dreyer 2004, Bahi et al., 2004b). 
Locomotor Activity measurement: One week after surgery, locomotor activity was 
monitored in MED-OFA-RS cages (MED Associates Inc. USA) during the dark cycle 
in daily sessions over 12 days, according to previously published procedures (Bahi et
al., 2004a, b). The animal was injected with 0.9 % saline solution, placed into the 
activity-monitoring cage for a 30 min baseline. After a 30 min period, the session 
automatically paused and during this interval, each subject received cocaine-HCl (15 
mg/kg, i.p.) and was then placed back into the locomotor activity-monitoring cage 
for further 60 min. Statistical evaluation of behavioral analysis was performed 
according to previous publications (see Bahi et al., 2004a, b): briefly, the activity 
monitor computed the location of the animal in each of the X and Y dimensions as 
the middle point between the extreme beam interruptions; speed was estimated by 
computing standard deviation of the distances of data points to their mean within a 
sliding time window 0.4 s wide. Within the same experimental group, means and 
standard deviations were done on measurements performed each day during one 
session. The T-test was done by comparison of the 6 animals (3 from each group) in 
the same time point and the p-value was calculated to check for the significance of 
the difference between the groups with and without doxycycline. 
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Results
Dopamine D3R expression is induced by cocaine
The expression of the dopamine DA D3R upon cocaine treatment was evaluated by 
means of microarray technology and quantitative real time-PCR. Microarrays were 
designed, and total RNA from NAcc of animals (n=6) treated under the three 
different paradigms were prepared, reverse transcribed and DA D3R together with 
DA D2R expression was assessed after normalization against GAPDH considered as 
endogenous control. Data were normalized to the values obtained from saline-
treated animals with saline levels set to 1. The results are shown in figure 1. DA D3R
mRNA was induced significantly after cocaine injection in all three paradigms. 
Strongest up-regulation was observed after “binge” treatment (four injections of 30 
mg/kg over 6h), under which conditions a 3-fold up-regulation of DA D3R in the 
NAcc has been found. DA D3R mRNA was also induced after acute and after chronic 
treatments, where a ~2-fold raise in expression was found in both cases. By contrast, 
expression of the very closely related DA D2R was not affected by cocaine under the 
same conditions, and DA D2R mRNA ratios between saline and cocaine treated 
animals were ~1 under all circumstances.
These expression levels could be confirmed by real time-PCR, using DA D2R and DA 
D3R specific primers. A 3.2-fold raise of DA D3R expression after binge treatment, 
resp. a ~1.8- and 2.3-fold change after acute or chronic treatment. The differences 
observed between the two latter treatments are not significant (P> 0.22 chronic vs 
acute). By contrast, no change for the DA D2R was found in all conditions. 
Subsequent in vivo studies were then performed according to the chronic paradigm. 
Lentivirus-mediated DA D3R expression in HEK293T cells
A tetracycline-regulatable lentivirus expressing DA D3R (Lenti-D3) was generated 
(see Methods). HEK293T cells were infected with different concentrations of Lenti-
D3. As controls, cells were co-infected with 4 Pl of two other tetracycline-regulatable 
lentiviruses, Lenti-CD81-His6 (Bahi et al., 2004a) and Lenti-uPA-His6 (Bahi et al.,
2004b). Transcripts levels were measured by means of quantitative real-time PCR 
and normalized against GAPDH used as endogenous control, with GAPDH levels 
set to 1. In absence of doxycycline, (figure 2A), control cells, infected with Lenti-GFP 
(instead of Lenti-D3) together with Lenti-CD81-His6 and Lenti-uPA-His6, displayed 
a basal level of DA D3R mRNA expression of ~1.0. In Lenti-D3 infected cells, DA D3R
mRNA expression was titer dependent, and a ~2-fold, ~3.6-fold and~7-fold increase 
was observed, respectively, with 2, 4 or 8 Pl viral stock. Under these conditions, 
Lenti-CD81-His6 and Lenti-uPA-His6 also induced the expression of CD81 and uPA 
(~3 and 2 fold increase, respectively), but their transcripts levels were not affected by 
Lenti-D3 titers. Endogenous E-actin mRNA was not affected under these conditions 
and a constant ~2.6 ratio was found under all conditions. Likewise, DA D2R
transcripts were not induced, indicating the specificity of DA D3R expression by 
Lenti-D3.
In presence of doxycycline (30 ng/ml in the culture medium during 96 h) Lenti-D3-
mediated DA D3R mRNA expression was completely abolished at lower virus 
concentrations (figure 2B) and DA D3R expression reached basal levels (ratio ~1). 
However, cells infected at highest virus titer (8 Pl of Lenti-D3) displayed residual 
Lenti-D3-mediated DA D3R expression (ratio ~3), as expression blockade by 30 
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ng/ml doxycycline was not complete due to a slight leackiness of the CMV 
promoter. Under these conditions, lentivirus-mediated expression of uPA and CD81 
transcripts were also fully blocked by doxycycline, in agreement with previous data 
(Bahi et al., 2004a and Bahi et al., 2004b) whereas DA D2R and E-actin levels were not 
affected (figure2B). It should be mentioned that mRNA levels were highly correlated 
with flagged DA D3R protein levels verified by means of immunohistochemitrsy 
(data not shown). 
 siRNAs-expressing lentiviruses and DA D3R silencing in vitro
In order to knock down DA D3R expression lentivirus-based RNA interference was 
used. Three different small interfering RNAs were designed, targeted against 
different regions of the DA D3R mRNA. Constructs holding a U6 promoter were 
inserted into the transfer plasmid of the lentivirus system and their efficiency at 
silencing DA D3R was assessed in vitro in Lenti-D3-infected HEK293T cells (figure 3). 
These lentivirus constructs are not doxycycline-regulated. Target specificity was 
controlled by co-infections of HEK293T cells with Lenti-CD81-His6 and Lenti-uPA-
His6 or with Lenti-GFP. 96h after infection, cells were harvested, total RNA was 
extracted and transcripts levels were measured by means of quantitative RT-PCR 
using specific primers for each candidate. All normalizations were performed against 
GAPDH. Cells co-infected with Lenti-D3, Lenti-uPA-His6 and Lenti-CD81-His6 were 
set-up to 100% of DA D3R expression level, used as control (figure 3, “A”). When 
Lenti-GFP was also added during co-infection, no significant change of DA D3R
mRNA levels was observed and ~98% of DA D3R transcripts were detected (figure 3, 
“B”), versus 100% in controls. In contrast, co-infection with Lenti-D3-siNRAs (either 
Lenti-D3-siRNA 1, 2, or 3) resulted in drastic DA D3R down-regulation, yielding 
residual DA D3R expression levels of 40%, 15% and 60%, respectively. (figure 3, “C”,
“D” and “E”). Co-infection in presence of all three Lenti-D3-siRNAs together 
resulted in >93% DA D3R mRNA knock down (figure 3, “F” and “G”). Under all 
conditions, the expression levels of other genes (DA D2R, E-actin, uPA or CD81 
mRNAs) were not affected by Lenti-D3-siRNAs, indicating that these targets are 
highly DA D3R-specific. The expression levels of control genes were ~35%, ~65%, 
~50% and ~54%, respectively. Immunohistochemistry with anti-flag antibody against 
flagged DA D3R showed that protein expression highly correlates with transcripts 
levels (data not shown). 
In vivo DA D3R silencing
In order to test the effects of Lenti-D3-siRNAs in vivo, the shell part of rat NAcc was 
stereotaxically injected in three sets of animals. After surgery, animals were left for 
recovery during 7 days, then were administered cocaine in three 5-days sessions, 
under the chronic paradigm (daily injections of 15 mg/kg i.p.). The first set of 
animals, fed without doxycycline, received cocaine and was sacrificed after the first 
5-days session; the second set received daily cocaine injection for 10 days being fed 
without doxycycline for 5 days, then with doxycycline added in the drinking water 
for another 5 day period, and animals were sacrificed; the third set of animals 
underwent the same schedule, but followed by a further 5-days period where 
doxycycline was again omitted, before animals were sacrificed. Each set consisted of 
4 groups of animals (n=9) which were operated as follows: the first group (n=9) was 
stereotaxically injected into the shell part of the NAcc with Lenti-D3 alone, to 
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evaluate the effects of DA D3R overexpression in vivo; the second group (n=9) was 
injected in the same brain region with Lenti-D3 together with a mix of the three 
Lenti-D3-siRNAs, in order to assess silencing of exogenous DA D3R in vivo; the third 
group (n=9) was injected with a mix of the three Lenti-D3-siRNAs together with 
Lenti-GFP (not Lenti-D3), to check for silencing of endogenous DA D3R; the last 
group (n=9) was injected with Lenti-GFP alone, a mock control, to evaluate 
endogenous DA D3R expression. After each 5-days session, one set (n=3) of animals 
per group was sacrificed, brains removed, NAcc tissues were dissected out and used 
for total RNA extraction. After reverse transcription, mRNA expression levels were 
measured by means of quantitative real time-PCR. Data are shown in figure 4. 
Data from the first set of animals (treated with cocaine over 5 days in absence of 
doxycycline, enabling local lentivirus-mediated DA D3R overexpression in the NAcc) 
is displayed in figure 4A, “SESSION A”. The first group of this set, infected only 
with Lenti-D3, displayed strong induction of DA D3R mRNA expression with a ratio 
of ~15 compared to GAPDH (set to 1), whereas the ratios of expression levels for DA 
D2R, E-actin, uPA and CD81, were ~1.5, ~1.3, ~6.3 and ~4.5, respectively. In full 
agreement with these data, we previously reported that chronic cocaine delivery 
induces uPA (6.3-fold, Bahi et al., 2004b) and CD81 (~4.2-fold, Bahi et al., 2004a) into 
the NAcc. The second group of this set, injected with Lenti-D3 together with a mix of 
Lenti-D3-siRNAs, displays drastic inhibition of DA D3R expression, resulting in a 
ratio of ~1.3, i.e. at least 11.5 fold inhibition (P<0.005 vs. Lenti-D3 infected animals). 
Lenti-D3-siRNAs had no effects at all on expression levels of DA D2R, E-actin, uPA 
and CD81, when compared to the first group of animals (P>0.25 vs. Lenti-D3 infected 
animals). In the third group of this set of animals, infected with the Lenti-D3-siRNAs 
and Lenti-GFP (not Lenti-D3), expression levels of all tested candidates are 
unchanged, except for DA D3R whose mRNA expression level was only~0.32, 
corresponding to silencing of the endogenous DA D3R mRNA (P<0.01 vs. Lenti-GFP 
infected animals). Finally, in the last group of this set, injected with Lenti-GFP, DA 
D3R expression was ~4.5, reflecting cocaine-mediated induction of endogenous DA 
D3R . This value, compared to that observed in the third group (0.32) indicates that a 
93% knock down of the endogenous DA D3R has been achieved with Lenti-D3-
siRNAs (P<0.01 vs. Lenti-GFP with Lenti-D3-siRNAs infected animals). In this same 
group, DA D2R, E-actin, uPA and CD81 mRNAs were unchanged. 
Results from the second set of animals, administered cocaine chronically and fed 
without doxycycline over 5 days, then switched to doxycycline over 5 days (resulting 
in down-regulation of lentivirus-mediated DA D3R in the NAcc) are displayed in 
figure 4B, “SESSION B”. The first group of this set, infected with Lenti-D3, displays 
cocaine-mediated DA D3R induction, with a ratio of 4.4, equivalent to the ratio 
observed for GFP-treated animals in the previous set (cocaine-mediated endogenous 
induction) and much lower than the ratio observed in absence of doxycycline (15 fold 
increase in “Session A” for Lenti-D3 treated animals). DA D2R, E-actin, uPA and 
CD81 mRNAs expression were not affected by doxycycline and ratios of ~1.6, ~1.1, 
~5.5, and ~3.9 respectively, similar to those observed in the previous session, were 
found. In the second group of this set, co-injected with Lenti-D3 together with Lenti-
D3-siRNAs mix, DA D3R expression is strongly inhibited (with ratios ~0.6, compared 
to 1.3 observed in the corresponding group fed without doxycycline, P<0.005 vs. 
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Lenti-D3 infected animals), because doxycycline blocks exogenous, lentiviral-
mediated DA D3R overexpression (but not the endogenously expressed DA D3R), 
while the silencers also block endogenous DA D3R. Under these conditions, the other 
targets were not modified at all (P>0.23 vs. Lenti-D3 infected animals). In the third 
group of this set, i.e. animals infected with Lenti-D3-siRNAs mix and Lenti-GFP, DA 
D3R expression is even lower, with a ratio ~0.5 (P<0.01 vs. Lenti-GFP infected 
animals) - since no exogenous DA D3R has been generated - and again DA D2R, E-
actin, uPA and CD81 were not modified (P>0.23 vs. Lenti-D3 infected animals). 
Finally in the last group of this set, infected with Lenti-GFP without Lenti-D3-siRNA, 
cocaine induced ~4.9-fold increase in DA D3R expression (compared to GAPDH set 
to 1), similar to the corresponding group in session A (fed without doxycycline), 
whereas the ratios of the other targets remained unchanged  (P>0.25 vs. Lenti-GFP 
infected animals in session A). 
Figure 4C ”SESSION C” displays observations from the third set of animals, which 
have been switched back to doxycycline-free regimen. The data coincide with 
observations made on the first set, which clearly establishes that cocaine-induced 
expression changes mediated by Lenti-D3- are reversible in a doxycycline-dependent 
manner. In the first group of this set (animals treated with Lenti-D3 in the shell part 
of the NAcc), chronic cocaine treatment again induced a ~15-fold increase of DA D3R
expression, identical to levels observed in the corresponding group from the first set, 
while DA D2R, E-actin, uPA and CD81 remained unmodified by regimen switch. In 
the second group of this set (animals co-infected with Lenti-D3-siRNAs and Lenti-
D3), again exogenous DA D3R expression was strongly inhibited, with ratios of ~1.6, 
while control genes remained unaffected also. In the third group of this set (animals 
treated with Lenti-D3-siRNAs and Lenti-GFP), DA D3R transcripts were lowest, as 
expected, with ratios of only ~0.6, corresponding to silencing of endogenous mRNA 
exclusively; in this group, again, DA D2R, E-actin, uPA and CD81 mRNAs were not 
modified and displayed no significant difference compared to the other groups (i.e. 
~1.7, ~1, ~6 and 3.7-fold cocaine-mediated increase, with P> 0.22 vs Lenti-D3 infected 
animals). In the last group (animals treated with Lenti-GFP alone, in absence of 
silencers), DA D3R expression was significantly induced compared to the third group 
(~4.5 versus ~0.6) and its level was comparable to the corresponding group from the 
first set. In this group, control genes were still unmodified: ~1.8, ~2.5, ~6.6 and ~4-
fold increase for DA D2R, E-actin, uPA and CD81 respectively; induction of the latter 
two candidates by cocaine again confirms previous observations (Bahi et al., 2004a, 
Bahi et al., 2004b) and is independent of lentiviral-injections.
Behavioral Changes induced upon Dopamine D3R Expression
Four groups of animals (n=9) were used to test the effects of DA D3R expression in 
the shell part of the NAcc on cocaine-induced behavioural changes. Lentivirus-
mediated overexpression of DA D3R and its local knock down were therefore used 
(figure 5). 
A first group of animals (n=9), infected with Lenti-GFP, served as a control group 
expressing GFP in the NAcc in a doxycycline-regulated way. After surgery, animals 
were fed water, enabling full expression of GFP in the target area. One week after 
surgery, chronic cocaine delivery was started and locomotor activity was monitored. 
At each daily session, animals received saline injections before the habituation period 
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(30 min) followed by cocaine delivery (i.p. 15 mg/kg) and the locomotor activity was 
monitored during 60 min immediately after drug injection. As shown in the figure 5
(Session A: GFP), after saline injection animals displayed low levels of locomotor 
activity (with total distance traveled over that period of ~4’458 counts), but after 
cocaine delivery a significant induction of locomotor activity was observed with a 
total distance traveled during that period of ~23’638 counts (means over five days 
session). After five days, the same animals (n=6) were fed with doxycycline in the 
drinking water, and locomotor activity upon chronic cocaine delivery was further 
monitored for five consecutive days. Under these conditions the distance traveled 
after saline injection during habituation period remained unchanged (~4’630 counts) 
and after cocaine injection it was not significantly different, with a total activity of 
~25’774 counts (P>0.23 vs. doxycycline free water-fed animals (Session A) (figure 5 
Session B: GFP). After further five days, the remaining animals (n=3) were fed 
without doxycycline, again enabling GFP expression; during this last session, 
locomotor activity remained unchanged again: after saline injection it remained at 
~4’590 counts and after cocaine delivery, it was comparable to the previous sessions, 
with a total activity of ~18’086 counts  (figure 5, Session C: GFP). These behavioural 
activity patterns cannot be attributed to GFP-expression, because uninfected rats 
showed identical results (P>0.21 vs. Lenti-GFP, data not shown). 
The second group of animals (n=9) was infected with the doxycycline-regulatable 
Lenti-D3 into the shell part of NAcc. After surgery, animals underwent the same 
regimen as the previous group: initially, animals (n=9) were fed water, enabling full 
expression of DA D3R in the targeted area and chronic cocaine delivery was started 
after one week together with locomotor activity monitoring. In daily sessions animals 
were receiving saline injections before the habituation period, followed, 30 min later, 
by cocaine delivery (i.p. 15 mg/kg) and locomotor activity was monitored. After 
saline delivery, locomotor activity remained comparable to the GFP control group 
(Lenti-GFP-treated animals, P>0.22) with total distance traveled over that period of 
~4’450 counts; but after cocaine injection, a significant decrease in locomotor activity 
was observed, compared to Lenti-GFP-treated animals, with a total activity of 16’626 
counts (figure 5, Session A: D3). After five days the same animals  (n=6) were fed with 
doxycycline in the drinking water (inducing down-regulation of lentivirus-induced 
expression of DA D3R in the NAcc), and their behaviour upon chronic cocaine 
treatment was further monitored for five consecutive days. Under these conditions 
the distance traveled during the habituation period was unchanged (~4’326 counts, 
P>0.25 vs. Lenti-D3, session A) whereas after cocaine injection, a total distance of 
~28’699 counts was observed (figure 5, Session B: D3). After five days under this 
regimen, doxycycline was removed (enabling re-expression of lentivirus-mediated 
DA D3R in the NAcc). Under these conditions, no changes were observed during the 
habituation period (total traveled distance ~4’731 counts, P>0.26 vs. Lenti-D3, session 
A & B), but locomotor activity returned back to its initial levels, with a total distance 
traveled of ~ 18’766 counts (figure 5, Session C: D3, n=3). The difference between 
sessions A and C was not significant (P> 0.2). 
A third group of animals was treated by co-injection of the regulatable Lenti-D3 
(same concentration as the first group) together with (non-regulatable) Lenti-D3-
siRNAs. Animals  (n=9) were then submitted to the same regimen and drug 
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treatment as the other groups: seven days after surgery, chronic cocaine delivery was 
initiated in absence of doxycycline, i.e. under conditions where lentivirus-mediated 
DA D3R expression was achieved (figure 5, Session A: D3 & siRNAs): during 
habituation, locomotor activity remained unchanged (~4’120 counts, P>0.22 vs. 
Lenti-D3), but after cocaine delivery locomotor activity was significantly higher than 
in the second group under the same conditions, with a total distance traveled over 
that period of 24’089 counts, corresponding to ~150% the locomotor activity 
monitored under the same conditions in absence of silencers Lenti-D3-siRNAs 
(P<0.05 vs. Lenti-D3). After five days, doxycycline was added to the regimen of 
animals (n=6), inducing down-regulation of exogenous, lentivirus-mediated DA D3R
expression, but not of lentivirus-mediated siRNAs, neither of endogenous induction 
of D3R (figure 5, Session B: D3 & siRNAs): locomotor activity, that remained 
unchanged during the habituation period (~4’656 counts, P>0.26 vs. Lenti-D3), 
further increased under these conditions, and reached a total traveled distance of 
38’203 counts, even significantly higher (~30%) than in corresponding GFP-treated 
animals (P<0.05). This high raise in locomotor activity most probably corresponds to 
silencing of the endogenous DA D3R that, in the absence of DA D3R-specific siRNAs, 
would be strongly induced by cocaine under these conditions. When doxycycline 
was removed from water on the same animals (n=3), enabling full expression of the 
Lenti-D3 in the NAcc, the locomotor activity is unmodified during the habituation 
period (~4’162 counts) but drops to the basal level, comparable to the second session 
(a total distance of 23’567 counts after cocaine delivery and; figure 5, Session C: D3 & 
siRNAs).
The fourth group of animals (n=9), co-infected with Lenti-GFP together with Lenti-
D3-siRNAs, served to assess effects from endogenous DA D3R. In absence of 
doxycycline, animals (n=9) displayed the same locomotor activity during the 
habituation period (~4’071 counts, P>0.25 vs. Lenti-D3), but a high locomotor activity 
after cocaine delivery, with a total traveled distance of ~33’343 counts (P<0.05 vs. 
Lenti-GFP) (figure 5, Session A: GFP & siRNAs). When switched to doxycycline 
regimen (n=6), five days later, no significant change was observed during the 
habituation period (~4’645 count, P>0.24 vs. Lenti-D3) but after cocaine delivery the 
total distance traveled was ~38’457 counts (P<0.05 vs. Lenti-GFP) (figure 5, Session B: 
GFP & siRNAs). Finally, five days later, doxycycline was removed from water to the 
remaining animals (n=3) and the locomotor activity after saline delivery was ~4’133
counts during the habituation period and 30’878 counts after cocaine delivery (P<0.05
vs. Lenti-GFP) (figure 5, Session C: GFP & siRNAs). The observed difference between 
these three sessions within this group of animals was not significant (P> 0.18). These 
observed behavioural effects were highly correlated with changes of the flagged DA 
D3R, as verified at protein levels by means of immunocytochemistry (data not 
shown).
The use of a regulatable system, described here, enables to minimize considerably 
the number of animals per set (n=3), since the very same animal can be used under 
different conditions (gene on/gene off, very locally, at will). Animals in sessions C 
are the very same as in sessions A; when the gene is turned on/off, behavioral data 
are repeated at will on the same animal (almost identical values in locomotor activity 
test, very good statistics, s.d.<12% even with n=3), yielding to highly reproducible 
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behavioural response on the very same animals in relation to local gene expression, 
whether before or after doxy switch. Thus data are equivalent to a group n=12 
expressing the gene (sessions A and C together) compared to a group n=6 without 
the gene (session B). With an unregulatable system, more and larger groups (N=8 at 
least, per group) would be necessary to reach similar statistical correlation.   
15
ht
tp
://
do
c.
re
ro
.c
h
Discussion
The present study aimed at clarifying the role of local expression of DA D3R in 
cocaine-induced hyperlocomotion. Activation of DA D3R inhibits locomotion 
(Svensson et al., 1994, Sokoloff and Schwartz, 1995), in agreement with our present 
study, but the mechanisms remains to be established. Low doses of the DA D3R
agonist, 7-OH-DPAT, preferentially activate DA D3R (Khroyan et al., 1995) and 
produce hypolocomotion (Daly and Waddington, 1993, Depoortere et al., 1996, 
Ouagazzal and Creese, 2000), while very high doses enhance locomotor activity, 
presumably through some action at DA D2R (Depoortere et al., 1996).  Therefore the 
potency of DA receptor agonists in producing hypolocomotion correlates somehow 
with the in vitro affinity for the DA D3R than the DA D2R subtype; in mutant animals 
(DA D3R-/- or DA D3R+/-), however, locomotor activity is either at, below, or above 
that of controls (Depoortere et al., 1996), indicating that the presence of DA D3R may 
not be necessary for the expression of behavioral effects induced by agonists or 
antagonists supposedly selective for the DA D3R subtype. Alternatively, of course, 
possible adaptive mechanisms taking place in DA D3R-/- mice might have 
compensated for the absence of DA D3R (Boulay et al., 1999).  Mice lacking the DA 
D3R display basal firing rates of DA neurons within both the substantia nigra and 
ventral tegmental area not different from wild-type mice (Koeltzow et al., 1998), 
although in vivo microdialysis studies of DA release in ventral striatum revealed 
higher basal levels of extracellular DA in mutant mice; thus DA D3R may not be 
significantly involved in DA autoreceptor function but rather participate in 
postsynaptically activated short-loop feedback modulation of DA release. In mutant 
mice, DA D2R could compensate for the loss of DA D3R, thereby masking functional 
loss, but the reciprocal is not true, i.e., DA D3R is unable to compensate for loss of DA 
D2R (Mercuri et al., 1997), suggesting that DA D2R is capable of autoregulation 
independently, whereas DA D3R autoregulatory activity would be dependent on 
concurrent DA D2R autoreceptor stimulation. As a matter of fact, lack of functional 
DA D2R prevents the effects of DA D3R agonists, indicating that DA D2R is necessary 
for DA D3R-mediated inhibition of presynaptic DA neurotransmission (Zapata and 
Schippenberg, 2005), in contrast to earlier data from DA D3R ko mice or 
pharmacological evidence that DA D3R activation regulates extracellular DA levels in 
the NAcc and inhibits DA release. Stimulation of DA D2R/D3R affects reward, 
locomotor activity and conditioned place preference; these effects are synergistically 
enhanced upon AMPA/kainate receptor blockade (Biondo et al., 2005) and 5-HT1b 
stimulation (Parson et al., 1996). Another approach to assessing DA D3R function - 
suppressing DA D3R expression by means of intracerebro-ventricular administration 
of DA D3R antisense oligodeoxynucleotide – revealed enhanced basal levels of DA 
synthesis in the NAcc but failed to affect the suppression of synthesis by the 
nonselective DA receptor agonist apomorphine (Nissbrandt et al., 1995; Tepper et al.,
1997); nevertheless this approach is not well suited for assessing long term effects of 
gene suppression in vivo and associated behavioral changes.
Because of the limitations associated to these various methods, another approach, 
based on regulatable lentiviral-mediated gene transfer, has been developed here. 
Self-inactivating lentiviruses permanently incorporate genetic elements into the 
infected target cells and do not diffuse away, enabling very local switch on/off of 
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gene expression on the very same animal for evaluating behavioral changes 
associated with local gene overexpression or suppression. Using these tools, our 
study clearly shows that suppression of DA D3R in the NAcc yields to cocaine 
induced hyperlocomotion (compared to controls), whereas its overexpression in the 
same brain area drastically reduced cocaine’s locomotor stimulant effects. Gene 
transfer of a mix of three siRNAs, targeting three different regions of the DA D3R
mRNA, most efficiently induces gene knock-down in vivo, stably yielding >93% gene 
silencing. However in the present investigation only a single dose of cocaine has 
been studied, and only one regimen (chronic cocaine delivery by means of repeated 
daily treatments); accordingly, the range of conditions under which decreased and 
increased effects of cocaine were observed is rather narrow, and information 
regarding how the potency and efficacy of cocaine as a locomotor stimulant may 
have been altered is limited. Furthermore, a major limitation of the approach lies in 
its own power: the lentivirus-mediated overexpression of DA D3R is driven by a 
promiscuous minimal CMV promoter that infected cells in the NAcc that do not 
normally express DA D3R; given the complex neuroanatomical circuitry in this brain 
region, observed behavioral changes related to this overexpression may not reflect an 
exaggeration of normal DA D3R function, but may relate to compensatory 
mechanisms taking place under such conditions. For the same reason, expression of 
exogenous D3 receptor and the silencing of endogenous and exogenous D3 receptors 
may not have been confined to the NAcc shell area - a rather small and deeply 
located brain region - and we cannot rule out that some amount of lentivirus found 
its way to the NAcc core or other adjacent nuclei, and there contributed to the 
observed behavioural effects.
Our investigation has been limited here to the effects of DA D3R expression in the 
NAcc shell on cocaine-induced locomotor changes. Measures of cocaine-induced 
locomotor activity are appropriate means to reveal behavioural effects of a drug and 
a reasonable indication that rewarding effects may be altered similarly; however 
additional studies will be still necessary to establish this, using appropriate 
behavioural measures of reinforcement and reward, such as self-administration, ICSS 
or conditioned place preference. Previous studies have shown that blockade of 
mesolimbic DA D3R inhibits stress-induced reinstatement of cocaine seeking in rats 
self-administering the drug, indicating that DA D3R plays an important role in 
mediating stress-induced reinstatement (Xi et al., 2004). DA D3R antagonists inhibit 
cocaine-seeking and cocaine-enhanced brain reward in rats (Vorel et al., 2002). DA 
D3R blockade attenuates both the rewarding effects of cocaine and cocaine-induced 
drug-seeking behavior, suggesting a role for DA D3R in mediating addictive 
properties of cocaine.  Neuroanatomical and functional investigations focusing on 
DA D3R have confirmed its potential role in psychiatric diseases such as drug 
dependence (Gurevich and Joyce, 1999, Landwehrmeyer et al, 1993b). The 
importance of DA D3R in addiction, in particular cocaine addiction, has been 
confirmed in other studies using animal models. Stimulation of DA D3R is not 
sufficient to modulate food-primed food-seeking behavior or alter incentive 
motivation for food, morphine, and/or associated cues, but it affects the perception 
of the rewarding value of cocaine; thus the appetitive effects of cocaine are subserved 
by mechanisms involving DA D3R and different, at least in part, from those of 
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morphine and food (Duarte et al., 2003). 7-OH-DPAT and quinpirole, selective DA 
D3R agonists, potently decreased cocaine self-administration in the rat at doses that 
were not, in themselves, reinforcing (Caine and Koob, 1993), in contrast to the DA 
D3R antagonist nafadotride and DA D2R agonists that modulate cocaine self-
administration in correlation with their relative potencies in vitro. Together these 
data support the hypothesis that the DA D3R may be an important target for 
pharmacotherapies for cocaine abuse and dependence (Caine et al., 1997). The cue 
properties of cocaine may be dissociated from its locomotor activating effects, 
because DA D3R/D2R agonists suppress locomotor activity but produce stimulus 
generalization to cocaine (Garner and Baker, 1999). Furthermore, in self-
administering monkeys, DA D3R agonists produce cocaine-like effects and may 
modulate the discriminative stimulus effects of cocaine (Lamas et al., 1996), that were 
attenuated by DA D2R antagonists (Spealman, 1996); in contrast, self-administration 
of the DA D3R agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine 
exposure (Nader and Mach, 1996). We believe that the lentiviral approach developed 
here may help clarifying these mechanisms by means of local manipulations of 
receptor expression.
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Figure Legends
Figure 1.
Microarray and Quantitative RT-PCR analysis of Cocaine-Induced DA D3R mRNA 
Expression. Panel A: Microarrays slides were prepared as described in the Methods 
Section. Candidates (70mer oligos) were spotted eight-fold, together with controls (10 
positive and 10 negative controls, see Methods). Animals (n=6) were administered 
cocaine or saline according to the different drug administration protocols “Acute” 
(A), “Binge” (B) or “Chronic” (C). After sacrifice, total RNA was extracted from the 
NAcc, hybridized as Cy3 (saline) or Cy5 (cocaine) cDNAs and DA D3R mRNA was 
quantified. DA D2R was used as a control. Relative abundance of candidate 
transcripts is expressed relative to GAPDH. Data were normalized to the values 
obtained from saline-treated animals with saline levels set to 1 (as described in the 
Methods Section). Real time-PCR was performed with the same RNA samples and 
amplifications were done using specific sets of primers; after normalization, the 
ratios between samples from cocaine-treated and saline-treated tissues were 
calculated (see Methods). Panel B: PCR products from cDNA used for microarrays or 
after real-time PCR were verified by 2% agarose gel electrophoresis and visualized 
with ethidium bromide staining. A: Acute; B: Binge; C: Chronic;. * P< 0.05 and ** P<
0.01 vs. saline-treated group.
Figure 2.
In vitro Expression of DA D3R mRNA in HEK293T cells: Quantification by means 
of Real-Time PCR. HEK293T cells were infected with 0, 2, 4 or 8 Pl of the Lenti-D3 
together with or without 4 Pl of Lenti-GFP, Lenti-CD81-Hi6 or Lenti-uPA-His6 in 
culture medium in presence or absence of doxycycline (30 ng/ml), as indicated. After 
96h, culture medium was removed and cells were used for total RNA extraction, 
cDNA preparation and quantitative real-time PCR using specific oligos. Results were 
normalized against GAPDH (set to 1)used as endogenous control. 
Panel A: Normalized transcript levels from cells infected without doxycycline. Panel
B: PCR products from panel A were verified by 2% agarose gel electrophoresis and 
visualized with ethidium bromide staining. C: Normalized transcript levels from 
cells infected in presence of doxycycline. D: PCR products from panel C were 
verified by 2% agarose gel electrophoresis and visualized with ethidium bromide 
staining. Control: non_infected HEK293 cells. * P< 0.05; ** P< 0.01 and *** P< 0.005 
vs. non infected cells
Figure 3.
In vitro Expression of DA D3R mRNA in HEK293T cells infected with Lenti-D3 
and Lenti-D3-siRNAs: HEK293T cells were infected with 4 Pl Lenti-D3 together with 
or without other viruses, as indicated. After 96h, culture medium was removed and 
cells were used for total RNA extraction, cDNA preparation and quantitative real-
time PCR using specific sets of primers. Results were normalized against GAPDH 
used as endogenous control. 
A: Lenti-D3 + Lenti-uPA-His6 + Lenti-CD81-His; B: Lenti-D3 + Lenti-GFP + Lenti-
uPA-His6 + Lenti-CD81-His; C: Lenti-D3 + Lenti-D3-siRNA1 + Lenti-uPA-His6 + 
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Lenti-CD81-His; D: Lenti-D3 + Lenti-D3-siRNA2 + Lenti-uPA-His6 + Lenti-CD81-
His; E: Lenti-D3 + Lenti-D3-siRNA3 + Lenti-uPA-His6 + Lenti-CD81-His; F: Lenti-D3 
+ mix of 2 Pl of all Lenti-D3-siRNAs + Lenti-uPA-His6 + Lenti-CD81-His; G: Lenti-D3 
+ mix of 4 Pl of all Lenti-D3-siRNAs + Lenti-uPA-His6 + Lenti-CD81-His. Panel A:
Residual mRNA levels, from quantitative RT-PCR. Panel B: PCR products from 
panel A were verified by 2% agarose gel electrophoresis and visualized with 
ethidium bromide staining. ** P< 0.05 and *** P< 0.005 vs. A (cells infected with 
Lenti-D3 + Lenti-uPA-His6 + Lenti-CD81-His).
Figure 4:
In vivo Silencing of DA D3R in the NAcc with Lenti-D3-siRNAs: Quantification of 
Transcripts by means of qRT-PCR. Animals (n=9) were bilaterally injected into the 
shell part of the NAcc with either Lenti-D3 alone, or Lenti-D3 together with a mix of 
all Lenti-D3-siRNAs, or only with a mix of Lenti-D3-siRNAs (no Lenti-D3), or with 
Lenti-GFP (as a control). Seven days after operation, animals were chronically 
injected with cocaine-HCl (i.p. 15 mg/kg), while control animals received 0.9% saline 
injections under the same schedule. Over 5 days, animals were fed without 
doxycycline (session A, n=9), yielding full overexpression of DA D3R in the injected 
brain areas and locomotor activity was monitored. On day-5 (session B), three 
animals per group were sacrificed and the other animals (n=6) were fed with 
doxycycline (immediately after the daily injection) and behavioural activity was 
measured after regimen switch; then animals were kept for five further days on the 
same regimen (session B, n=6). On day-10, three animals per group were sacrificed 
and for the remaining animals (n=3) regimen was switched back and animals were 
fed without doxycycline for five days (session C, n=3), allowing DA D3R
overexpression in the injected areas and its return to levels observed in session A. At 
the end of each session, three rats per group were sacrificed by decapitation 24h after 
the last injection; the NAcc’s were dissected out and used for total RNA isolation, 
cDNA preparation and quantitative real-time PCR using specific oligos (n=3). 
Results were normalized against GAPDH (set to 1). ** P< 0.01 and *** P< 0.005, vs.
data from Lenti-D3 infected rats. 
Figure 5.
Cocaine-induced Behavioral Changes of Locomotor Activity Monitoring upon in
vivo Dopamine D3R Receptor Silencing in the NAcc. Four groups of animals (n=9) 
were bilaterally injected into the NAcc, (a) either Lenti-D3 alone, (b) Lenti-D3 
together with a mix of Lenti-D3-siRNAs, (c) Lenti-GFP alone or (d) Lenti-GFP 
together with Lenti-D3-siRNAs. Seven days after operation, animals (n=9) were 
chronically treated with cocaine (15 mg/kg) each day and locomotor activity was 
monitored. For each session, animals were injected with saline solution prior to the 
habituation period and placed in the monitoring cage for 30 min until stable basal 
activity was measured. Cocaine (15 mg/kg, i.p.) was then injected and the animal 
returned to the cage for further 60 min while locomotor activity monitoring was 
monitored.  Initially, animals were fed without doxycycline over five days, yielding 
full overexpression of DA D3R in the injected brain area (Session A, n=9); on day-5, 
three animals per group were sacrificed and the other animals (n=6) were fed 
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doxycycline for five further days (Session B, n=6); finally, on day-10, three animals 
per group were sacrificed and for the other animals (n=3) regimen was switched back 
and animals were fed without doxycycline for five days (Session C, n=3), yielding 
DA D3R re-expression in the injected areas, as in session A.
Values indicate means r SE (over the five days of each session) of total counts of 
locomotor activity during the 30 min habituation period (saline) and during the 60 
min cocaine-induced period (cocaine). * P<0.05, ** P<0.01 and *** P<0.005 vs. 
corresponding saline-treated rats;  P<0.05 vs. Lenti-D3 infected animals;  P<0.05 vs. 
Lenti-GFP infected animals; z P<0.05 vs. doxycycline-fed animals (Session B). 
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